Broadmeadows, VIC, Australia
CSL Limited will construct a biopharmaceutical R&D facility in Broadmeadows, Victoria. The $235 million project includes infrastructure improvements to CSL’s existing manufacturing campus to enhance integration with the new building. The R&D facility will support late stage development of treatments for cancer, bleeding disorders, inflammation, and infection.
